tiprankstipranks
Elite Pharmaceuticals Launches Generic Pain Medication
Company Announcements

Elite Pharmaceuticals Launches Generic Pain Medication

Don't Miss our Black Friday Offers:

The latest announcement is out from Elite Pharmaceuticals ( (ELTP) ).

Elite Pharmaceuticals, Inc. has announced the commercial launch of its generic version of Tylenol® with Codeine in various dosages, marking a significant step in the company’s niche generic product offerings. The medication is intended for the management of mild to moderate pain where an opioid is appropriate, and alternatives are inadequate, boasting sales of approximately $47 million in the past year. With its facilities in Northvale, NJ, Elite Pharmaceuticals continues to develop and manufacture controlled-release oral dose products, contributing to the competitive pharmaceutical market.

See more data about ELTP stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskElite Pharmaceuticals Gains FDA Approval for Generic Vyvanse
TipRanks Auto-Generated NewsdeskElite Pharmaceuticals Reports Robust Q2 Financial Growth
TipRanks Auto-Generated NewsdeskElite Pharmaceuticals Reports Strong Q2 2025 Financial Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App